Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IIITerminatedJul 13, 2022Mometasone FuroateDefective ContainerGlenmark Pharmaceuticals Inc., USA · D-1173-2022Class IITerminatedJul 6, 2022Fluticasone Propionate Nasal SprayDefective container: defect prevents product from dispensing as intended.Akorn, Inc. · D-1172-2022Class IITerminatedJul 6, 2022Desmopressin Acetate TabletsCGMP DeviationsGlenmark Pharmaceuticals Inc., USA · D-1171-2022Class IITerminatedJul 6, 2022Calcipotriene Topical SolutionDefective Delivery System: Potential defect that could prevent the product from dispensing as intended.Akorn, Inc. · D-1170-2022Class IIOngoingJul 6, 2022DaytranaDefective Delivery System: Customer complaints received for ripping patches and tight release/adhesive transfer.Noven Pharmaceuticals Inc · D-1169-2022Class ITerminatedJul 6, 2022TegsediSuperpotent: High Out of specification (OOS) test result for percent label claim (%LC).Akcea Therapeutics, Inc. · D-1166-2022Class ITerminatedJul 6, 2022SnoreStop NasoSprayMicrobial contamination of non-sterile product: FDA laboratory analysis found product to contain microbial contamination identified as Providencia rettgeri.Green Pharmaceuticals, Inc. · D-1165-2022Class IITerminatedJul 6, 2022Losartan potassium & Hydrochlorothiazide Tablets 100 mg/25 mgCGMP Deviations- AZIDO Impurity levels observed to be above acceptable limitsMacleods Pharma Usa Inc · D-1164-2022Class IITerminatedJul 6, 2022Losartan Potassium TabletsCGMP Deviations- AZIDO Impurity levels observed to be above acceptable limitsPD-Rx Pharmaceuticals, Inc. · D-1163-2022Class IITerminatedJul 6, 2022Losartan Potassium TabletsCGMP Deviations- AZIDO Impurity levels observed to be above acceptable limitsPD-Rx Pharmaceuticals, Inc. · D-1162-2022Class IITerminatedJul 6, 2022Losartan Potassium TabletsCGMP Deviations- AZIDO Impurity levels observed to be above acceptable limitsPD-Rx Pharmaceuticals, Inc. · D-1161-2022Class ITerminatedJul 6, 2022Allergy Bee Gone for Kids Nasal Swab Remedy 0.33 FL OZMicrobial contamination of non-sterile product: FDA laboratory analysis found product to contain elevated levels of yeast and mold as well as the presence of Bacillus...Buzzagogo, LLC · D-1160-2022Class IITerminatedJun 29, 2022Tretinoin CapsulesFailed Dissolution Specifications; Low Out of Specification (OOS) results for dissolution.Teva Pharmaceuticals USA Inc · D-1156-2022Class IITerminatedJun 29, 2022Clonazepam Orally Disintegrating TabletsFailed Tablet/Capsule Specification; oversized tablet found in a bottleSun Pharmaceutical Industries Inc · D-1155-2022Class IITerminatedJun 29, 2022Testosterone Cypionate InjectionLack of Assurance of Sterility: Manufacturing deviation which was reported due to a microbial excursionSun Pharmaceutical Industries Inc · D-1154-2022Class IITerminatedJun 29, 2022Testosterone Cypionate InjectionCGMP Deviations: lots made with same active pharmaceutical ingredient (API) as lots that were rejected due to manufacturing issues that could cause the product to be out...Sun Pharmaceutical Industries Inc · D-1153-2022Class IITerminatedJun 29, 2022Clonidine Transdermal SystemDefective Delivery System: Out of specification for release liner removal force results at the 3-month CRT stability timepoint.Mayne Pharma Inc · D-1152-2022Class IITerminatedJun 29, 202270% ISOPROPYL ALCOHOL First aid antisepticDefective Container: Product may leak when squeezed or when not in an upright position determined to be due to defects in the bottle neck finish and insufficient...Vi-Jon, LLC · D-1151-2022Class IICompletedJun 22, 2022Artri King Reforzado con Ortiga Omega 3 TabletsMarketed Without An Unapproved NDA/ANDA: All lots were found to be unapproved drugs based on labeling claims.Walmart Inc · D-1159-2022Class IICompletedJun 22, 2022Artri Ajo King Reforzado con Ortiga y Omega 3 TabletsMarketed Without An Unapproved NDA/ANDA: All lots were found to be unapproved drugs based on labeling claims.Walmart Inc · D-1158-2022Class ICompletedJun 22, 2022Artri King Reforzado con Ortiga Omega 3 TabletsMarketed Without An Unapproved NDA/ANDA: Product lot found to be tainted with undeclared diclofenac, an FDA approved nonsteroidal anti-inflammatory drug (NSAID) for the...Walmart Inc · D-1157-2022Class IITerminatedJun 22, 2022Zileuton Extended-Release TabletsFailed Dissolution Specifications: Out of specification test results observed in dissolution testing during long term stability study.Lupin Pharmaceuticals Inc. · D-1150-2022Class IITerminatedJun 22, 2022HAND SANITIZER SAY GOODBYE TO GERMS Alcohol Antiseptic 80% Topical Non-Sterile SolutionCGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.Hand Sanitizer LLC · D-1149-2022Class IIOngoingJun 22, 2022Premium Nature Instant Hand SanitizerSubpotent Drug: FDA analysis has revealed some bottles of these products were sub potent for ethanol.AMS Packaging Inc · D-1148-2022Class IITerminatedJun 22, 2022medroxyPROGESTERone Acetate Injectable SuspensionLack of assurance of sterilitySun Pharmaceutical Industries Inc · D-1147-2022Class IITerminatedJun 22, 2022medroxyPROGESTERone Acetate Injectable SuspensionLack of assurance of sterilitySun Pharmaceutical Industries Inc · D-1146-2022Class IITerminatedJun 22, 2022medroxyPROGESTERone Acetate Injectable SuspensionLack of assurance of sterilitySun Pharmaceutical Industries Inc · D-1145-2022Class IITerminatedJun 22, 2022medroxyPROGESTERone Acetate Injectable SuspensionLack of assurance of sterilitySun Pharmaceutical Industries Inc · D-1144-2022Class IITerminatedJun 22, 2022medroxyPROGESTERone Acetate Injectable SuspensionLack of assurance of sterilitySun Pharmaceutical Industries Inc · D-1143-2022Class IIOngoingJun 22, 2022Alcohol Antiseptic 80%CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.A.P. Nonweiler · D-1142-2022Class IITerminatedJun 22, 2022VaccinotoxinumcGMP deviationsWashington Homeopathic Products, Inc. · D-1141-2022Class IITerminatedJun 22, 2022Tuberculinum BovinumcGMP deviationsWashington Homeopathic Products, Inc. · D-1140-2022Class IITerminatedJun 22, 2022TuberculinumcGMP deviationsWashington Homeopathic Products, Inc. · D-1139-2022Class IITerminatedJun 22, 2022SyphilinumcGMP deviationsWashington Homeopathic Products, Inc. · D-1138-2022Class IITerminatedJun 22, 2022StreptococcinumcGMP deviationsWashington Homeopathic Products, Inc. · D-1137-2022Class IITerminatedJun 22, 2022PyrogeniumcGMP deviationsWashington Homeopathic Products, Inc. · D-1136-2022Class IITerminatedJun 22, 2022Proteus, Potency: 7CcGMP deviationsWashington Homeopathic Products, Inc. · D-1135-2022Class IITerminatedJun 22, 2022PertussinumcGMP deviationsWashington Homeopathic Products, Inc. · D-1134-2022Class IITerminatedJun 22, 2022MorbillinumcGMP deviationsWashington Homeopathic Products, Inc. · D-1133-2022Class IITerminatedJun 22, 2022MedorrhinumcGMP deviationsWashington Homeopathic Products, Inc. · D-1132-2022